Antineoplaston A10

DB11702InvestigationalSmall molecule

Antineoplaston A10 has been used in trials studying the treatment of Sarcoma, Lymphoma, Lung Cancer, Liver Cancer, and Kidney Cancer, among others.

Chemical structure of Antineoplaston A10
Formula / weight
C13H14N2O3 · 246.266 g/mol (avg)
Also known as
Antineoplaston A 10 · ATENGENAL · BENZENEACETAMIDE, N-((3S)-2,6-DIOXO-3-PIPERIDINYL)- · BENZENEACETAMIDE, N-(2,6-DIOXO-3-PIPERIDINYL)-, (S)-

Resolves to

Compound
UNII16VY3TM7ZOCAS91531-30-5ChEMBLCHEMBL1980825PubChem56260
Structure
InChIKeyOQGRFQCUGLKSAV-JTQLQIEISA-NSMILESO=C(CC1=CC=CC=C1)N[C@H]1CCC(=O)NC1=O

What you can answer from here — as of April 02, 2025

60Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Antineoplaston A10, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In